In this final episode, Dr Rasha Al-Lamee and Dr Darren Mylotte provide a comprehensive summary of where we are currently with DCB and then look forwards by exploring the evolving landscape of DCB and their potential applications in the future.
This podcast series is supported by Medtronic.
All content for DCB Unveiled: Bridging Science and Application is the property of Radcliffe Cardiology, supported by Medtronic and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this final episode, Dr Rasha Al-Lamee and Dr Darren Mylotte provide a comprehensive summary of where we are currently with DCB and then look forwards by exploring the evolving landscape of DCB and their potential applications in the future.
This podcast series is supported by Medtronic.
Ep 5: What is the Difference Between the Two Drugs in the Context of DCB?
DCB Unveiled: Bridging Science and Application
15 minutes 30 seconds
1 year ago
Ep 5: What is the Difference Between the Two Drugs in the Context of DCB?
Join host Dr Rasha Al-Lamee in this exciting new episode, as she is joined by Prof Michael Joner and Prof Bruno Scheller to delve into the distinctive properties of two commonly utilised drugs in the field of DCB.
Increase your understanding of these products by tuning in to this enlightening 15-minute discussion, where you will gain insights on key features and the safety profile, provided with the latest updates from the FDA.
This podcast series is supported by Medtronic.
DCB Unveiled: Bridging Science and Application
In this final episode, Dr Rasha Al-Lamee and Dr Darren Mylotte provide a comprehensive summary of where we are currently with DCB and then look forwards by exploring the evolving landscape of DCB and their potential applications in the future.
This podcast series is supported by Medtronic.
